Skip to content

Long-term Effect of tDCS in Patients With Disorders of Consciousness

Long-term Effect of 20 Sessions of Transcranial Direct Current Stimulation in Patients With Disorders of Consciousness: a Double Blind Sham Controlled Clinical Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03114397
Enrollment
62
Registered
2017-04-14
Start date
2017-09-01
Completion date
2021-12-24
Last updated
2022-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorder of Consciousness

Brief summary

In this multicentric double-blind sham controlled study, the investigators plan to assess the effects of 20 sessions of tDCS on long-term behavioral recovery in patients with disorders of consciousness. Neurophysiological outcomes (EEG) will also be collected. This research will 1) determine whether long-term behavioral recovery can be promoted with tDCS and 2) generate knowledge regarding the impact of tDCS on neurophysiological outcome (i.e., EEG) in severely brain injured patients. The investigators will compare the effects of active and sham tDCS on behavioral assessments and quantitative EEG in patients with severe brain injury and its potential application in rehabilitation.

Interventions

transcranial direct current stimulation will be applied over the left dorsolateral at 2 mA for 20minutes.

transcranial direct current stimulation will be applied over the left dorsolateral at 2 mA for 20minutes. The sham intervention consists of 30 seconds of stimulation at the beginning and the end of the 20minutes of intervention.

Sponsors

Fondazione Salvatore Maugeri, Italy
CollaboratorUNKNOWN
Université Catholique de Louvain, Belgium
CollaboratorUNKNOWN
Hospitales Nisa, Spain
CollaboratorUNKNOWN
I.R.C.C.S. Fondazione Santa Lucia, Italy
CollaboratorUNKNOWN
Schoen Clinic Bad Aibling, Germany
CollaboratorUNKNOWN
Research Center of Neurology, Russia
CollaboratorOTHER_GOV
Therapiezentrum Burgau, Germany
CollaboratorUNKNOWN
pavlov state medical university, Russia
CollaboratorUNKNOWN
Azienda Unita Sanitaria Locale di Piacenza, Italy
CollaboratorUNKNOWN
University of Liege
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* CNS medication stable for at least a week * Stable diagnosis (no diagnosis change based on 2 CRS-R performed within 1 week). * Between 3 and 24 months post injury * Structural MRI or CT-scan (to evidence focal lesions on the left DLPFC)

Exclusion criteria

* Craniotomies encompassing the frontal region (electrodes location) * VPS under the stimulated area (prefrontal cortex) * Pacemaker * Metallic cerebral implant * Severe medical conditions that might influence clinical diagnosis and EEG activity (e.g., severe hepatic insufficiency or renal failure, or sub-continuous or abundant epileptiform discharges on standard EEG recordings).

Design outcomes

Primary

MeasureTime frameDescription
Change in the CRS-R total score4 weeksImprovement of the CRS-R total score after the end of the anodal session.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026